ChiCTR2000038546 版本V1.2 版本创建时间2020/11/30 00:58:15 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2000038546 

最近更新日期:

Date of Last Refreshed on:

2020-11-30 00:55:10 

注册时间:

Date of Registration:

2020-09-23 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

孕产期疲乏对子代发育的危害及干预效果评估

Public title:

Evaluation of the harm of pregnancy and childbirth fatigue to the development of offspring and its intervention effect

注册题目简写:

English Acronym:

研究课题的正式科学名称:

孕产期疲乏对子代发育的危害及干预效果评估

Scientific title:

Evaluation of the harm of pregnancy and childbirth fatigue to the development of offspring and its intervention effect

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

柏婷 

研究负责人:

张凤 

Applicant:

Bai Ting 

Study leader:

Zhang Feng 

申请注册联系人电话:

Applicant telephone:

+86 18306293295

研究负责人电话:

Study leader's telephone:

+86 13814715979

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

1161707283@qq.com

研究负责人电子邮件:

Study leader's E-mail:

zhangfeng820909@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

江苏省南通市启秀路19号

研究负责人通讯地址:

江苏省南通市启秀路19号

Applicant address:

19 Qixiu Road, Nantong, Jiangsu, China

Study leader's address:

19 Qixiu Road, Nantong, Jiangsu, China

申请注册联系人邮政编码:

Applicant postcode:

226001

研究负责人邮政编码:

Study leader's postcode:

226001

申请人所在单位:

南通大学医学院(护理学院 )

Applicant's institution:

School of Nursing, Medical College, Nantong University

研究负责人所在单位:

南通大学医学院(护理学院 )

Affiliation of the Leader:

School of Nursing, Medical College, Nantong University

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

Y2020010

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

南通市妇幼保健院伦理委员会

Name of the ethic committee:

Ethics Committee of Nantong Maternal and Child Health Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2020-09-03 00:00:00

伦理委员会联系人:

刘华华

Contact Name of the ethic committee:

Liu Huahua

伦理委员会联系地址:

江苏省南通市崇川区世纪大道399号

Contact Address of the ethic committee:

399 Shiji Dadao, Chongchuan District, Nantong, Jiangsu Province, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

南通大学医学院(护理学院)

Primary sponsor:

School of Nursing, Medical College, Nantong University

研究实施负责(组长)单位地址:

江苏省南通市启秀路19号

Primary sponsor's address:

19 Qixiu Road, Nantong, Jiangsu, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

江苏省

市(区县):

南通市

Country:

China

Province:

Jiangsu

City:

Nantong

单位(医院):

南通大学

具体地址:

江苏省南通市崇川区啬园路9号

Institution
hospital:

Nantong university

Address:

9 Qiangyuan Road, Chongchuan District, Nantong

经费或物资来源:

国家自然科学基金项目

Source(s) of funding:

National Natural Science Foundation of China

Target disease:

The harm of pregnancy and childbirth fatigue to the development of offspring

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

I期临床试验 

Study phase:

1

研究设计:

析因分组(即根据危险因素或暴露因素分组) 

Study design:

Factorial 

研究目的:

(1)构建孕产期疲乏临床评估指标体系。 (2)构建产妇产时疲乏的影响因素的理论模型。 (3)探讨孕产期疲乏对子代生长发育的影响。  

Objectives of Study:

(1)To construct the clinical evaluation index system of fatigue during pregnant and puerperal period. (2)To construct a theoretical model of the influencing factors of maternal fatigue during childbirth. (3)To explore the effect of pregnancy and childbirth fatigue on the growth and development of offspring.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

(1)年龄≥18周岁的孕产妇及其子代;
(2)理解认知能力正常,有清晰的表达能力。

Inclusion criteria

1. The maternal aged >=18 years old and their offspring;
2. Normal understanding and cognitive ability, clear expression ability.

排除标准:

(1)孕产妇有慢性疲乏史或孕前抑郁症史;
(2)孕产妇有遗传代谢性疾病或染色体异常疾病者;
(3)产检筛查胎儿有染色体异常性疾病高风险(可疑或确诊);
(4)孕产妇有慢性腹泻、活动性结核、严重肾病或心脏病等影响婴儿发育的疾病。

Exclusion criteria:

(1) Women with a history of chronic fatigue or pre-pregnancy depression;
(2) Pregnant women with genetic metabolic diseases or chromosomal abnormalities;
(3) Prenatal examination screening fetuses with high risk of chromosomal abnormalities (suspicious or confirmed);
(4) Maternal has chronic diarrhea, active tuberculosis, serious kidney disease or heart disease and other diseases that affect the development of the baby.

研究实施时间:

Study execute time:

From 2020-09-25 00:00:00 To 2023-09-25 00:00:00  

征募观察对象时间:

Recruiting time:

From 2020-09-25 00:00:00 To 2023-09-25 00:00:00  

干预措施:

Interventions:

组别:

孕期疲乏组

样本量:

86

Group:

Pregnancy fatigue group

Sample size:

干预措施:

测量疲乏和胎儿发育指标

干预措施代码:

Intervention:

Measures fatigue and fetal development indicators

Intervention code:

组别:

孕期非疲乏组

样本量:

86

Group:

Non-fatigue during pregnancy

Sample size:

干预措施:

测量疲乏和胎儿发育指标

干预措施代码:

Intervention:

Measures fatigue and fetal development indicators

Intervention code:

组别:

产时疲乏组

样本量:

276

Group:

Labor fatigue group

Sample size:

干预措施:

测量疲乏影响因素指标

干预措施代码:

Intervention:

The index of fatigue influencing factors was measured.

Intervention code:

组别:

产后疲乏组

样本量:

209

Group:

Postpartum fatigue group

Sample size:

干预措施:

测量疲乏和子代结局指标

干预措施代码:

Intervention:

Fatigue and offspring outcome measures were measured.

Intervention code:

组别:

产后非疲乏组

样本量:

209

Group:

Non-fatigue during postpartum

Sample size:

干预措施:

测量疲乏和子代结局指标

干预措施代码:

Intervention:

Fatigue and offspring outcome measures were measured.

Intervention code:

组别:

产时非疲乏组

样本量:

276

Group:

Non-fatigue during labor

Sample size:

干预措施:

测量疲乏影响因素指标

干预措施代码:

Intervention:

The index of fatigue influencing factors was measured.

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

江苏 

市(区县):

南通 

Country:

China 

Province:

Jiangsu 

City:

Nantong 

单位(医院):

南通市妇幼保健院 

单位级别:

三甲医院 

Institution
hospital:

Nantong Maternal and Child Health Hospital

Level of the institution:

Tertiary A Hospital

国家:

中国

省(直辖市):

江苏 

市(区县):

南通 

Country:

China 

Province:

Jiangsu 

City:

Nantong 

单位(医院):

南通市第一人民医院 

单位级别:

三甲医院 

Institution
hospital:

Nantong First People's Hospital

Level of the institution:

Tertiary A Hospital

国家:

中国

省(直辖市):

江苏 

市(区县):

南通 

Country:

China 

Province:

Jiangsu 

City:

Nantong 

单位(医院):

南通大学附属医院 

单位级别:

三甲医院 

Institution
hospital:

Affiliated Hospital of Nantong University

Level of the institution:

Tertiary A Hospital

测量指标:

Outcomes:

指标中文名:

疲乏

指标类型:

主要指标

Outcome:

Fatigue

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

胎儿生长发育

指标类型:

主要指标

Outcome:

Fetal growth and development

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

婴儿体格发育

指标类型:

主要指标

Outcome:

Infant physical development

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

婴儿神经心理发育

指标类型:

主要指标

Outcome:

Neuropsychological development of infants

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

婴儿早期认知-运动发育

指标类型:

主要指标

Outcome:

Early cognitive-motor development in infants

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

睡眠

指标类型:

主要指标

Outcome:

Sleep

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

焦虑、抑郁

指标类型:

次要指标

Outcome:

Anxiety, depression

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

社会支持

指标类型:

次要指标

Outcome:

Social support

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

孕妇重大生活事件

指标类型:

次要指标

Outcome:

Major life events for pregnant women

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

分娩结局

指标类型:

次要指标

Outcome:

Delivery outcome

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

宫缩情况

指标类型:

次要指标

Outcome:

Contractions situation

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

患者血糖(产后2h)

指标类型:

次要指标

Outcome:

Blood glucose (2h postpartum)

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

患者满意度

指标类型:

次要指标

Outcome:

Patient satisfaction

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

疼痛

指标类型:

次要指标

Outcome:

Pain

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

胎盘

组织:

Sample Name:

Placenta

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

标本中文名:

脐血

组织:

Sample Name:

Umbilical cord blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

标本中文名:

血液

组织:

Sample Name:

Blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

简单随机

Randomization Procedure (please state who generates the random number sequence and by what method):

Simple randomization

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

2023年9月3日之前,采用网络平台。

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

By September 3, 2023, the network platform will be adopted.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

电子采集和管理系统

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Electronic Data Capture, EDC

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2020-09-23 09:42:08